Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro

.blurhash-client-img { display: none !important; }

Open Access

|Jun 2023

Authors

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China

Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus), Beijing, China

DOI: https://doi.org/10.2478/acph-2023-0015 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Language: English

Page range: 269 - 280

Accepted on: Dec 3, 2022

Published on: Jun 12, 2023

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2023 Rui Liu, Cuihong Jiang, Zhizheng Zhao, Yutong Lv, Gaoxing Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.